Stabilized pharmaceutical composition containing bupropion
US5731000A · kind A · utility
111Cited by
21References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 1996 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | Mar 22, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.